Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion
ConclusionsXi ’an criterion has a similar or even higher ability to distinguish high-risk PBC patients than other published criteria. Xi’an criterion can facilitate early identification of patients requiring new therapeutic approaches.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Bilirubin | Cirrhosis | Infectious Diseases | Liver | Liver Transplant | Training | Transplants | Universities & Medical Training | Urology & Nephrology